natgillin/translations-raw huggingface dataset:
Therefore, it is appropriate to maintain certain traditional products on the market in some Member States where the use of food additives comply with the general and specific conditions laid down in Regulation (EC) No 1333/2008.
Stoga je primjereno određene tradicionalne proizvode zadržati na tržištu u nekim državama članicama ako je uporaba prehrambenih aditiva u skladu s općim i posebnim uvjetima utvrđenima u Uredbi (EZ) br. 1333/2008.
In order to ensure uniform application of the use of additives covered by the present regulation, ‘golonka peklowana’ will be described in the guidance document describing the food categories in Part E of Annex II to Regulation (EC) No 1333/2008 on food additives [3].
Kako bi se osigurala ujednačena uporaba aditiva obuhvaćenih ovom Uredbom, „golonka peklowana” bit će opisana u smjernicama iz Dijela E Priloga II. Uredbi (EZ) br. 1333/2008 o prehrambenim aditivima, kojima se opisuju kategorije hrane [3].
Pursuant to Article 3(2) of Regulation (EC) No 1331/2008, the Commission has to seek the opinion of the European Food Safety Authority (the Authority) in order to update the Union list of food additives set out in Annex II to Regulation (EC) No 1333/2008, except where the update in question is not liable to have an effect on human health.
U skladu s člankom 3. stavkom 2. Uredbe (EZ) br. 1331/2008 za ažuriranje Unijina popisa prehrambenih aditiva iz Priloga II. Uredbi (EZ) br. 1333/2008 Komisija treba zatražiti mišljenje Europske agencije za sigurnost hrane („Agencija”), osim ako predmetno ažuriranje vjerojatno neće utjecati na zdravlje ljudi.
Nitrites are authorised for the use in meat products on a general basis, the use in meat preparations is restricted to certain traditional preparations and specific provisions are laid down for traditionally cured meat products.
Uporaba nitrita u mesnim proizvodima općenito je odobrena, uporaba u mesnim pripravcima ograničena je na određene tradicionalne pripravke, a za tradicionalno salamurene mesne proizvode utvrđene su posebne odredbe.
Since the application for the extension of use of nitrites is limited to the specific meat preparation that has been traditionally used it is not expected that the extension will have a significant impact on the overall exposure to nitrites.
Budući da je zahtjev za proširenje uporabe nitrita ograničen na određeni mesni pripravak koji se tradicionalno upotrebljava, ne očekuje se da će proširenje znatno utjecati na ukupnu izloženost nitritima.
Therefore, the extended use of these additives constitutes an update of the Union list which is not liable to have an effect on human health and it is not necessary to seek the opinion of the Authority.
Stoga proširena uporaba tih aditiva predstavlja ažuriranje popisa Unije koje vjerojatno neće utjecati na zdravlje ljudi i nije potrebno zatražiti mišljenje Agencije.
Annex II to Regulation (EC) No 1333/2008 should be amended accordingly.
Prilog II. Uredbi (EZ) br. 1333/2008 trebalo bi na odgovarajući način izmijeniti.
In Part E of Annex II to Regulation (EC) No 1333/2008, in food category 08.2 ‘Meat preparations as defined by Regulation (EC) No 853/2004’, the entry for nitrites (E 249-250) is replaced by the following:
U Dijelu E Priloga II. Uredbi (EZ) br. 1333/2008, u kategoriji hrane 08.2 „Mesni pripravci kako su definirani Uredbom (EZ) br. 853/2004”, unos za nitrite (E 249–250) zamjenjuje se sljedećim:
only lomo de cerdo adobado, pincho moruno, careta de cerdo adobada, costilla de cerdo adobada, Kasseler, Bräte, Surfleisch, toorvorst, šašlõkk, ahjupraad, kiełbasa surowa biała, kiełbasa surowa metka, tatar wołowy (danie tatarskie) and golonka peklowana’
samo lomo de cerdo adobado, pincho moruno, careta de cerdo adobada, costilla de cerdo adobada, Kasseler, Bräte, Surfleisch, toorvorst, šašlõkk, ahjupraad, kiełbasa surowa biała, kiełbasa surowa metka, tatar wołowy (danie tatarskie) i golonka peklowana”
Commission Implementing Regulation (EU) 2017/840
Provedbena uredba Komisije (EU) 2017/840
concerning the non-approval of the active substance orthosulfamuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market
o neodobravanju aktivne tvari ortosulfamuron u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja
In accordance with Article 6(2) of Directive 91/414/EEC Italy received on 4 July 2005 an application from Isagro S.p.A. for the inclusion of the active substance orthosulfamuron in Annex I to Directive 91/414/EEC.
U skladu s člankom 6. stavkom 2. Direktive 91/414/EEZ Italija je 4. srpnja 2005. od trgovačkog društva Isagro S.p.A. primila zahtjev za uvrštenje aktivne tvari ortosulfamuron u Prilog I. Direktivi 91/414/EEZ.
Decision 2006/806/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Odlukom 2006/806/EZ potvrđeno je da je dokumentacija „cjelovita” te se može smatrati da u načelu ispunjava zahtjeve u pogledu podataka i informacija iz priloga II. i III. Direktivi 91/414/EEZ.
For that active substance, the effects on human and animal health and the environment have been assessed, in accordance with the provisions of Article 6(2) and (4) of Directive 91/414/EEC, for the uses proposed by the applicant.
Za tu su aktivnu tvar, za uporabe koje je predložio podnositelj zahtjeva. ocijenjeni učinci na zdravlje ljudi, zdravlje životinja te na okoliš u skladu s odredbama iz članka 6. stavaka 2. i 4. Direktive 91/414/EEZ.
The designated rapporteur Member State submitted a draft assessment report on 27 July 2012.
Imenovana država članica izvjestiteljica dostavila je 27. srpnja 2012. nacrt izvješća o ocjeni.
In accordance with Article 6(3) of Commission Regulation (EU) No 188/2011 [4] additional information was requested from the applicant.
U skladu s člankom 6. stavkom 3. Uredbe Komisije (EU) br. 188/2011 [4] od podnositelja zahtjeva zatražene su dodatne informacije.
The evaluation by Italy of the additional information submitted by the applicant was submitted in the format of addenda to the draft assessment report and compiled by the European Food Safety Authority (hereinafter ‘the Authority’) in August 2013.
Ocjenu dodatnih informacija koje je dostavio podnositelj zahtjeva Italija je dostavila u obliku dopuna nacrtu izvješća o ocjeni, a sastavila ih je Europska agencija za sigurnost hrane (dalje u tekstu „Agencija”) u kolovozu 2013.
The draft assessment report was reviewed by the Member States and the Authority.
Nacrt izvješća o ocjeni pregledale su države članice i Agencija.
The Authority presented to the Commission its conclusion on the pesticide risk assessment of the active substance orthosulfamuron [5] on 3 September 2013.
Agencija je 3. rujna 2013. Komisiji dostavila svoj zaključak o ocjeni rizika od pesticida koji sadržava aktivnu tvar ortosulfamuron [5].
The Authority concluded that the information available on the nature of residues in primary and succeeding crops in combination with a lack of toxicological information and intake assessment on some plant metabolites does not allow finalising the assessment of the consumer risk.
Agencija je zaključila da dostupne informacije o prirodi ostataka u primarnim kulturama i kulturama u plodoredu u kombinaciji s nedostatkom toksikoloških informacija i procjene unosa u pogledu nekih biljnih metabolita ne dopuštaju dovršetak procjene rizika za potrošače.
In addition, also the risk assessment to soil dwelling organisms and aquatic organisms could not be finalised.
Osim toga, nije se mogla dovršiti ni procjena rizika za organizme u tlu i vodene organizme.
Moreover, the Authority identified concerns from some metabolites, and consequently the exposure assessment to groundwater could not be finalised.
Uz to, Agencija je utvrdila da postoje razlozi za zabrinutost zbog nekih metabolita te se nije mogla dovršiti ni procjena izloženosti podzemnim vodama.
The Commission invited the applicant to submit its comments on the conclusion of the Authority, and, in accordance with Article 9(1) of Regulation (EU) No 188/2011 on the draft review report.
Komisija je pozvala podnositelja zahtjeva da podnese svoje primjedbe o zaključku Agencije i, u skladu s člankom 9. stavkom 1. Uredbe (EU) br. 188/2011, o nacrtu izvješća o pregledu.
However, despite the arguments put forward by the applicant, the concerns identified/referred to in recital 4 could not be eliminated.
Međutim, unatoč argumentima koje je iznio podnositelj zahtjeva, zabrinutost na koju se upućuje u uvodnoj izjavi 4. nije se mogla otkloniti.
Consequently it has not been demonstrated that it may be expected that, under the proposed conditions of use, plant protection products containing orthosulfamuron satisfy in general the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC.
Dakle, nije dokazano da se može očekivati da, u predloženim uvjetima uporabe, sredstva za zaštitu bilja koja sadržavaju ortosulfamuron u načelu ispunjavaju zahtjeve iz članka 5. stavka 1. točaka (a) i (b) Direktive 91/414/EEZ.
Orthosulfamuron should therefore not be approved pursuant to Article 13(2) of Regulation (EC) No 1107/2009.
Ortosulfamuron stoga ne bi trebalo odobriti u skladu s člankom 13. stavkom 2. Uredbe (EZ) br. 1107/2009.
In accordance with Article 8(1)(b) of Directive 91/414/EEC, Member States were given the possibility to grant provisional authorisations for plant protection products containing orthosulfamuron for an initial period of three years.
U skladu s člankom 8. stavkom 1. točkom (b) Direktive 91/414/EEZ državama članicama omogućeno je izdavanje privremenih odobrenja za sredstva za zaštitu bilja koja sadržavaju ortosulfamuron na početno razdoblje od tri godine.
Commission Implementing Decision 2013/205/EU [6] allowed Member States to extend provisional authorisations for orthosulfamuron for a period ending on 30 April 2015 at the latest.
Provedbenom odlukom Komisije 2013/205/EU [6] državama članicama dopušteno je produljenje privremenih odobrenja za ortosulfamuron za razdoblje koje završava najkasnije 30. travnja 2015.
As all existing authorisations have expired, it is not necessary to provide an additional period to withdraw authorisations for plant protection products containing orthosulfamuron.
Budući da je istekao rok svih postojećih odobrenja, nije potrebno odrediti dodatno razdoblje za povlačenje odobrenja za sredstva za zaštitu bilja koja sadržavaju ortosulfamuron.
This Regulation does not prejudice the submission of a further application for orthosulfamuron in accordance with Article 7 of Regulation (EC) No 1107/2009.
Ovom se Uredbom ne dovodi u pitanje ponovno podnošenje zahtjeva za ortosulfamuron u skladu s člankom 7. Uredbe (EZ) br. 1107/2009.
The active substance orthosulfamuron is not approved.
Aktivna tvar ortosulfamuron ne odobrava se.
Commission Decision 2006/806/EC of 24 November 2006 recognising in principle the completeness of the dossier submitted for detailed examination in view of the possible inclusion of orthosulfamuron in Annex I to Council Directive 91/414/EEC (OJ L 329, 25.11.2006, p. 74).
Odluka Komisije 2006/806/EZ od 24. studenoga 2006. o načelnom priznavanju cjelovitosti dokumentacije podnesene na detaljno razmatranje s ciljem mogućeg uvrštenja ortosulfamurona u Prilog I. Direktivi Vijeća 91/414/EEZ (SL L 329, 25.11.2006., str. 74.).
Commission Regulation (EU) No 188/2011 of 25 February 2011 laying down detailed rules for the implementation of Council Directive 91/414/EEC as regards the procedure for the assessment of active substances which were not on the market 2 years after the date of notification of that Directive (OJ L 53, 26.2.2011, p. 51).
Uredba Komisije (EU) br. 188/2011 od 25. veljače 2011. o utvrđivanju detaljnih pravila za provedbu Direktive Vijeća 91/414/EEZ u pogledu postupka ocjene aktivnih tvari koje nisu bile na tržištu u 2 godine nakon priopćenja o toj direktivi (SL L 53, 26.2.2011., str. 51.).
EFSA Journal 2013;11(9):3352.
EFSA Journal 2013.;11(9):3352.
In accordance with Article 80(1)(a) of Regulation (EC) No 1107/2009, Council Directive 91/414/EEC [2] is to apply, with respect to the procedure and the conditions for approval, to active substances for which a decision has been adopted in accordance with Article 6(3) of that Directive before 14 June 2011.
U skladu s člankom 80. stavkom 1. točkom (a) Uredbe (EZ) br. 1107/2009, Direktiva Vijeća 91/414/EEZ [2] primjenjuje se, u odnosu na postupak i uvjete za odobravanje, na aktivne tvari za koje je prije 14. lipnja 2011. donesena odluka u skladu s člankom 6. stavkom 3. te direktive.
For orthosulfamuron the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2006/806/EC [3].
Odlukom Komisije 2006/806/EZ [3] potvrđeno je da ortosulfamuron ispunjava uvjete iz članka 80. stavka 1. točke (a) Uredbe (EZ) br. 1107/2009.
Commission Implementing Regulation (EU) 2017/841
Provedbena uredba Komisije (EU) 2017/841
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja roka valjanosti odobrenja aktivnih tvari: alfa-cipermetrin, Ampelomyces quisqualis soja: aq 10, benalaksil, bentazon, bifenazat, bromoksinil, karfentrazon etil, klorprofam, ciazofamid, desmedifam, dikvat, DPX KE 459 (flupirsulfuron-metil), etoksazol, famoksadon, fenamidon, flumioksazin, foramsulfuron, Gliocladium catenulatum soja: j1446, imazamoks, imazosulfuron, izoksaflutol, laminarin, metalaksil-m, metoksifenozid, milbemektin, oksasulfuron, pendimetalin, fenmedifam, pimetrozin, s-metolaklor i trifloksistrobin
The approval periods of the active substances bentazone, diquat, DPX KE 459 (flupyrsulfuron-methyl), famoxadone, flumioxazine, metalaxyl-m and pymetrozine were last extended by Commission Implementing Regulation (EU) 2016/549 [3].
Rokovi valjanosti odobrenja aktivnih tvari bentazon, dikvat, DPX KE 459 (flupirsulfuron-metil), famoksadon, flumioksazin, metalaksil-m i pimetrozin posljednji put su produljeni Provedbenom uredbom Komisije (EU) 2016/549 [3].
The approval periods of the active substances carfentrazone ethyl, cyazofamid, fenamidone, foramsulfuron, imazamox, isoxaflutole, oxasulfuron, pendimethalin, and trifloxystrobin were last extended by Commission Implementing Regulation (EU) 2016/950 [6].The approval of those substances will expire on 31 July 2017.
Rokovi valjanosti odobrenja aktivnih tvari karfentrazon etil, ciazofamid, fenamidon, foramsulfuron, imazamoks, izoksaflutol, oksasulfuron, pendimetalin i trifloksistrobin posljednji put su produljeni Provedbenom uredbom Komisije (EU) 2016/950 [6].Odobrenje tih tvari prestaje važiti 31. srpnja 2017.
The approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum strain: j1446, imazosulfuron, laminarin, methoxyfenozide, milbemectin, phenmedipham, and s-metolachlor were extended by Commission Implementing Regulation (EU) No 1197/2012 [7].
Rokovi valjanosti odobrenja aktivnih tvari alfa-cipermetrin, Ampelomyces quisqualis soja: aq 10, benalaksil, bifenazat, bromoksinil, klorprofam, desmedifam, etoksazol, Gliocladium catenulatum soja: j1446, imazosulfuron, laminarin, metoksifenozid, milbemektin, fenmedifam i s-metolaklor produljeni su Provedbenom uredbom Komisije (EU) br. 1197/2012 [7].
The approval of those substances will expire on 31 July 2017.
Odobrenje tih tvari prestaje važiti 31. srpnja 2017.
Applications for the renewal of the approval of substances listed in recitals 3 and 4 were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 [8].
Zahtjevi za produljenje odobrenja tvari navedenih u uvodnim izjavama 3. i 4. podneseni su u skladu s Provedbenom uredbom Komisije (EU) br. 844/2012 [8].
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009 u slučajevima u kojima Komisija donosi uredbu kojom se predviđa da se odobrenje aktivne tvari iz Priloga ovoj Uredbi ne produljuje jer nisu ispunjena mjerila za odobravanje, Komisija kao datum isteka određuje isti datum koji je vrijedio prije donošenja te Uredbe ili datum stupanja na snagu uredbe kojom se predviđa da se odobrenje aktivne tvari ne produljuje, ovisno o tome koji je datum kasniji.
As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.
U slučajevima u kojima Komisija donosi uredbu kojom se predviđa produljenje odobrenja aktivne tvari iz Priloga ovoj Uredbi, Komisija nastoji, u skladu s okolnostima, odrediti najraniji mogući datum primjene.
Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl (OJ L 95, 9.4.2016, p. 4).
Provedbena uredba Komisije (EU) 2016/549 оd 8. travnja 2016. o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja roka valjanosti odobrenja aktivnih tvari: bentazon, cihalofop butil, dikvat, famoksadon, flumioksazin, DPX KE 459 (flupirsulfuron-metil), metalaksil-M, pikolinafen, prosulfuron, pimetrozin, tiabendazol i tifensulfuron-metil (SL L 95, 9.4.2016., str. 4.)
in the sixth column, expiration of approval, of row 11 Bentazone, the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 11., bentazon, datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 15 Diquat, the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 15., dikvat, datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 19 DPX KE 459 (flupyrsulfuron-methyl), the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 19., DPX KE 459 (flupirsulfuron-metil), datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 23 Pymetrozine, the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 23., pimetrozin, datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 35 Famoxadone, the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 35., famoksadon, datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 37 Metalaxyl-M, the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 37., metalaksil-m, datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 39 Flumioxazine, the date is replaced by ‘30 June 2018’;
u šestom stupcu, prestanak odobrenja, u retku 39., flumioksazin, datum se zamjenjuje datumom „30. lipnja 2018.”;
In the sixth column, expiration of approval, of row 41 Imazamox, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 41., imazamoks, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 42 Oxasulfuron, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 42., oksasulfuron, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 44 Foramsulfuron, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 44., foramsulfuron, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 46 Cyazofamid, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 46., ciazofamid, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 53 Pendimethalin, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 53., pendimetalin, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 59 Trifloxystrobin, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 59., trifloksistrobin, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 60 Carfentrazone ethyl, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 60., karfentrazon etil, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 62 Fenamidone, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 62., fenamidon, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 63 Isoxaflutole, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 63., izoksaflutol, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 78 Chlorpropham, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 78., klorprofam, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 83 Alpha-cypermethrin, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 83., alfa-cipermetrin, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 84 Benalaxyl, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 84., benalaksil, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 85 Bromoxynil, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 85., bromoksinil, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 86 Desmedipham, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 86., desmedifam, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 88 Phenmedipham, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 88., fenmedifam, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 93 Ampelomyces quisqualis Strain: AQ 10, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 93., Ampelomyces quisqualis soja: AQ 10, datum se zamjenjuje datumom „31. srpnja 2018.”;
In the sixth column, expiration of approval, of row 95 Laminarin, the date is replaced by ‘31 July 2018’;
u šestom stupcu, prestanak odobrenja, u retku 95., laminarin, datum se zamjenjuje datumom „31. srpnja 2018.”;